Tropicamide

Registered South African indications:

• Mydriasis
• Cyloplegia

Contraindications

• Hypersensitivity to the active ingredient or any of its excipients
• Closed angle glaucoma
• Narrow filtration angle

Cautions 

• Pregnancy
• Breastfeeding
• Inflamed eye
• Paediatrics

Forms avail. in SA and covered in this monograph: opd

Mydriatic 
Cycloplegic

• Ophthalmic (opd): Initial: 1-2 drops into eye(s); Repeat after 5min; A further 1-2 drops after 30min may be given if needed

Treatment regimens are specialist dependent and may be tailored based on individual assessment

See additional prescribing points

Paed. forms avail. in SA and covered in this monograph: opd

Mydriatic
Cycloplegic

• Treatment regimens are specialist dependent and may be tailored based on individual assessment

See additional prescribing points

Pregnancy

• FDA Pregnancy Category C

Breastfeeding

• Caution

Renal Impairment

• No dose adjustment recommended

Hepatic Impairment

• No dose adjustment recommended

Elderly

• No dose adjustment recommended

Gastrointestinal Disorders

• Dry mouth 

Sensory Disorders

• Transient stinging
• Blurred vision

None known

Intraocular pressure 

Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops

Tropicamide is a parasympatholytic agent. It competes with acetylcholine for uptake at the receptor sites, thereby blocking its action. The results are mydriasis, due to unopposed action of the dilator pupillae, and cycloplegia.

Eye drops (per ml) 10mg

• Minims Tropicamide 1% (Soflens) oriinator
• Mydriacyl (Alcon) originator